dihexa side effects safety Side Effects | INQOVI® (decitabine

Hexosamine pathway Excess glucose not metabolized via glycolysis can enter the hexosamine pathway, which leads to increased production of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), which is used for O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins

Rotate injection sites to prevent tissue damage and maintain optimal absorption

sulfonate salts such as methanesulfonate (mesylate), ethanesulfonate (esylate), 2-hydroxyethanesulfonate (isethionate), benzenesulfonate (besylate), p-toluenesulfonate (tosylate), 2-naphthalenesulfonate (napsylate), 3-phenylsulfonate, or camphorsulfonate salts

Increases cellular NAD and SAM availability and lowers intracellular 1-MNA, consistent with enhanced NAD salvage and a favorable methyl economy [13]

1.5 mL bac water: 15 mg 1.5 mL = 10 mg/mL